Ampio granted IND for inhaled COVID-19 therapy Ampio Pharmaceuticals has received Investigational New Drug (IND) authorization from the U.S. Food and Drug Administration, allowing it to conduct additional clinical trials to test Ampion inhalation therapy for patients with COVID-19.
PharmAbcine, Samsung Biologics expand partnership PharmAbcine and Samsung Biologics have entered into a new strategic partnership for the development and manufacturing of PMC-403, a next-generation antibody therapeutic candidate to treat neovascular disorders.
Celebration of postdocs transitions to virtual platform For the first time ever, the National Postdoctoral Association will celebrate National Postdoc Appreciation Week from September 21-25 as a virtual, collaborative event among multiple institutions. Executive Director Tom Kimbis discusses how the organization is adapting to meet the challenges of COVID-19 to support and advocate for postdocs. Discuss